Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

Neurobiology of Disease

Volumn 94, Issue , 2016, Pages 213-225

  Bez, Francesco ^a   Francardo, Veronica ^a   Cenci, M Angela ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

6 Hydroxydopamine; Ageing; Mouse; Neuroplasticity; Parkinson's disease

Indexed keywords

APOMORPHINE; TRANSCRIPTION FACTOR DELTA FOSB; DOPAMINE; LEVODOPA; OXIDOPAMINE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DORSAL STRIATUM; FEMALE; IMMUNOREACTIVITY; LEVODOPA-INDUCED DYSKINESIA; LOCOMOTION; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC NERVE CELL; STEREOTYPY; THALAMUS VENTRAL NUCLEUS; UPREGULATION; YOUNG ADULT; AGING; ANIMAL; C57BL MOUSE; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECTS; DYSKINESIA; METABOLISM; MOTOR ACTIVITY; PARKINSON DISEASE; PHYSIOLOGY;

AGING; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DYSKINESIA, DRUG-INDUCED; LEVODOPA; MICE, INBRED C57BL; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE;

EID: 84977266542     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.06.005     Document Type: Article

References (69)

1. Andersson, M., Hilbertson, A., Cenci, M.A., Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 6 (1999), 461–474.
2. Andersson, M., Konradi, C., Cenci, M.A., cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 21 (2001), 9930–9943.
3. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F., Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20 (1973), 415–455.
4. Berton, O., Guigoni, C., Li, Q., Bioulac, B.H., Aubert, I., Gross, C.E., Dileone, R.J., Nestler, E.J., Bezard, E., Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biol. Psychiatry 66 (2009), 554–561.
5. Bezard, E., Gross, C.E., Brotchie, J.M., Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci. 26 (2003), 215–221.
6. Bichler, Z., Lim, H.C., Zeng, L., Tan, E.K., Non-motor and motor features in LRRK2 transgenic mice. PLoS One, 8, 2013, e70249.
7. Brehm, N., Bez, F., Carlsson, T., Kern, B., Gispert, S., Auburger, G., Cenci, M.A., A genetic mouse model of Parkinson's disease shows involuntary movements and increased postsynaptic sensitivity to apomorphine. Mol. Neurobiol. 52 (2015), 1152–1164.
8. Burke, S.N., Barnes, C.A., Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7 (2006), 30–40.
9. Calne, D.B., Zigmond, M.J., Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch. Neurol. 48 (1991), 361–363.
10. Cao, X., Yasuda, T., Uthayathas, S., Watts, R.L., Mouradian, M.M., Mochizuki, H., Papa, S.M., Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements. J. Neurosci. 30 (2010), 7335–7343.
11. Carlsson, T., Carta, M., Munoz, A., Mattsson, B., Winkler, C., Kirik, D., Bjorklund, A., Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain J. Neurol. 132 (2009), 319–335.
12. Carlsson, T., Winkler, C., Burger, C., Muzyczka, N., Mandel, R.J., Cenci, A., Bjorklund, A., Kirik, D., Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain J. Neurol. 128 (2005), 559–569.
13. Cenci, M.A., Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front. Neurol., 5, 2014, 242.
14. Cenci, M.A., Campbell, K., Bjorklund, A., Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57 (1993), 275–296.
15. Cenci, M.A., Kalen, P., Mandel, R.J., Wictorin, K., Bjorklund, A., Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 46 (1992), 943–957.
16. Cenci, M.A., Konradi, C., Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog. Brain Res. 183 (2010), 209–233.
17. Cenci, M.A., Lundblad, M., Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. J. Neurochem. 99 (2006), 381–392.
18. Cenci, M.A., Whishaw, I.Q., Schallert, T., Animal models of neurological deficits: how relevant is the rat?. Nat. Rev. Neurosci. 3 (2002), 574–579.
19. Collier, T.J., O'Malley, J., Rademacher, D.J., Stancati, J.A., Sisson, K.A., Sortwell, C.E., Paumier, K.L., Gebremedhin, K.G., Steece-Collier, K., Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration. Neurobiol. Dis. 77 (2015), 191–203.
20. de Lau, L.M., Breteler, M.M., Epidemiology of Parkinson's disease. Lancet Neurol. 5 (2006), 525–535.
21. Dickstein, D.L., Weaver, C.M., Luebke, J.I., Hof, P.R., Dendritic spine changes associated with normal aging. Neuroscience 251 (2013), 21–32.
22. Drouin-Ouellet, J., Sawiak, S.J., Cisbani, G., Lagace, M., Kuan, W.L., Saint-Pierre, M., Dury, R.J., Alata, W., St-Amour, I., Mason, S.L., Calon, F., Lacroix, S., Gowland, P.A., Francis, S.T., Barker, R.A., Cicchetti, F., Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology. Ann. Neurol. 78 (2015), 160–177.
23. Eskow, K.L., Dupre, K.B., Barnum, C.J., Dickinson, S.O., Park, J.Y., Bishop, C., The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats. Synapse 63 (2009), 610–620.
24. Farrall, A.J., Wardlaw, J.M., Blood-brain barrier: ageing and microvascular disease–systematic review and meta-analysis. Neurobiol. Aging 30 (2009), 337–352.
25. Fearnley, J.M., Lees, A.J., Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain J. Neurol. 114:Pt 5 (1991), 2283–2301.
26. Feyder, M., Sodersten, E., Santini, E., Vialou, V., LaPlant, Q., Watts, E.L., Spigolon, G., Hansen, K., Caboche, J., Nestler, E.J., Fisone, G., A role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and FosB expression. Biol. Psychiatry 79 (2016), 362–371.
27. Fieblinger, T., Cenci, M.A., Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia. Mov. Disord. 30 (2015), 484–493.
28. Fieblinger, T., Graves, S.M., Sebel, L.E., Alcacer, C., Plotkin, J.L., Gertler, T.S., Chan, C.S., Heiman, M., Greengard, P., Cenci, M.A., Surmeier, D.J., Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat. Commun., 5, 2014, 5316.
29. Finkelstein, D.I., Stanic, D., Parish, C.L., Tomas, D., Dickson, K., Horne, M.K., Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97 (2000), 99–112.
30. Francardo, V., Bez, F., Wieloch, T., Nissbrandt, H., Ruscher, K., Cenci, M.A., Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain J. Neurol. 137:Pt 7 (2014), 1998–2014 (Jul).
31. Francardo, V., Cenci, M.A., Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse. Parkinsonism Relat. Disord. 20:Suppl. 1 (2014), S20–S22.
32. Francardo, V., Recchia, A., Popovic, N., Andersson, D., Nissbrandt, H., Cenci, M.A., Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol. Dis. 42 (2011), 327–340.
33. Guerra, M.J., Liste, I., Labandeira-Garcia, J.L., Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. Neuroreport 8 (1997), 3485–3488.
34. Halliday, G.M., Holton, J.L., Revesz, T., Dickson, D.W., Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 122 (2011), 187–204.
35. Iderberg, H., Francardo, V., Pioli, E.Y., Animal models of L-DOPA-induced dyskinesia: an update on the current options. Neuroscience 211 (2012), 13–27.
36. Ingham, C.A., Hood, S.H., Arbuthnott, G.W., Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res. 503 (1989), 334–338.
37. Iravani, M.M., McCreary, A.C., Jenner, P., Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia. Parkinsonism Relat. Disord. 18:Suppl. 1 (2012), S123–S125.
38. Keller, A., Westenberger, A., Sobrido, M.J., Garcia-Murias, M., Domingo, A., Sears, R.L., Lemos, R.R., Ordonez-Ugalde, A., Nicolas, G., da Cunha, J.E., Rushing, E.J., Hugelshofer, M., Wurnig, M.C., Kaech, A., Reimann, R., Lohmann, K., Dobricic, V., Carracedo, A., Petrovic, I., Miyasaki, J.M., Abakumova, I., Mae, M.A., Raschperger, E., Zatz, M., Zschiedrich, K., Klepper, J., Spiteri, E., Prieto, J.M., Navas, I., Preuss, M., Dering, C., Jankovic, M., Paucar, M., Svenningsson, P., Saliminejad, K., Khorshid, H.R., Novakovic, I., Aguzzi, A., Boss, A., Le Ber, I., Defer, G., Hannequin, D., Kostic, V.S., Campion, D., Geschwind, D.H., Coppola, G., Betsholtz, C., Klein, C., Oliveira, J.R., Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat. Genet. 45 (2013), 1077–1082.
39. Kempster, P.A., Williams, D.R., Selikhova, M., Holton, J., Revesz, T., Lees, A.J., Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain J. Neurol. 130 (2007), 2123–2128.
40. Kordower, J.H., Olanow, C.W., Dodiya, H.B., Chu, Y., Beach, T.G., Adler, C.H., Halliday, G.M., Bartus, R.T., Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain J. Neurol. 136 (2013), 2419–2431.
41. Lee, C.S., Cenci, M.A., Schulzer, M., Bjorklund, A., Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain J. Neurol. 123:Pt 7 (2000), 1365–1379.
42. Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., Cenci, M.A., Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci. 15 (2002), 120–132.
43. Lundblad, M., Picconi, B., Lindgren, H., Cenci, M.A., A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16 (2004), 110–123.
44. Magen, I., Chesselet, M.F., Genetic mouse models of Parkinson's disease. The state of the art. Prog. Brain Res. 184 (2010), 53–87.
45. Manson, A., Stirpe, P., Schrag, A., Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life. J. Parasit. Dis. 2 (2012), 189–198.
46. Maries, E., Kordower, J.H., Chu, Y., Collier, T.J., Sortwell, C.E., Olaru, E., Shannon, K., Steece-Collier, K., Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 21 (2006), 165–180.
47. Marsden, C.D., Parkinson's disease. Postgrad. Med. J. 68 (1992), 538–543.
48. Mattson, M.P., Chan, S.L., Duan, W., Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 82 (2002), 637–672.
49. McClung, C.A., Ulery, P.G., Perrotti, L.I., Zachariou, V., Berton, O., Nestler, E.J., DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 132 (2004), 146–154.
50. Miguez, J.M., Aldegunde, M., Paz-Valinas, L., Recio, J., Sanchez-Barcelo, E., Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging. J. Neural. Transm. (Vienna) 106 (1999), 1089–1098.
51. Moore, H., Grace, A.A., A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology 27 (2002), 980–992.
52. Murer, M.G., Moratalla, R., Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front. Neuroanat., 5, 2011, 51.
53. Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., McKenzie, J., McCormick, S., Ruth, T.J., Sossi, V., de la Fuente-Fernandez, R., Stoessl, A.J., Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain J. Neurol. 134 (2011), 3290–3298.
54. Ohlin, K.E., Francardo, V., Lindgren, H.S., Sillivan, S.E., O'Sullivan, S.S., Luksik, A.S., Vassoler, F.M., Lees, A.J., Konradi, C., Cenci, M.A., Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain J. Neurol. 134 (2011), 2339–2357.
55. Ohlin, K.E., Sebastianutto, I., Adkins, C.E., Lundblad, C., Lockman, P.R., Cenci, M.A., Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. NeuroImage 61 (2012), 228–239.
56. Parish, C.L., Stanic, D., Drago, J., Borrelli, E., Finkelstein, D.I., Horne, M.K., Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur. J. Neurosci. 16 (2002), 787–794.
57. Politis, M., Wu, K., Loane, C., Brooks, D.J., Kiferle, L., Turkheimer, F.E., Bain, P., Molloy, S., Piccini, P., Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. J. Clin. Invest. 124 (2014), 1340–1349.
58. Roussakis, A.A., Politis, M., Towey, D., Piccini, P., Serotonin-to-dopamine transporter ratios in Parkinson disease: relevance for dyskinesias. Neurology 86 (2016), 1152–1158.
59. Rozas, G., Liste, I., Guerra, M.J., Labandeira-Garcia, J.L., Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci. Lett. 245 (1998), 151–154.
60. Rylander, D., Parent, M., O'Sullivan, S.S., Dovero, S., Lees, A.J., Bezard, E., Descarries, L., Cenci, M.A., Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann. Neurol. 68 (2010), 619–628.
61. Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., Soininen, H., Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur. J. Neurosci. 34 (2011), 3–11.
62. Shoji, H., Takao, K., Hattori, S., Miyakawa, T., Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age. Mol. Brain, 9, 2016, 11.
63. Song, D.D., Haber, S.N., Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci. 20 (2000), 5102–5114.
64. Stanic, D., Parish, C.L., Zhu, W.M., Krstew, E.V., Lawrence, A.J., Drago, J., Finkelstein, D.I., Horne, M.K., Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J. Neurochem. 86 (2003), 329–343.
65. van Luijtelaar, M.G., Tonnaer, J.A., Steinbusch, H.W., Aging of the serotonergic system in the rat forebrain: an immunocytochemical and neurochemical study. Neurobiol. Aging 13 (1992), 201–215.
66. Van Luijtelaar, M.G., Wouterlood, F.G., Tonnaer, J.A., Steinbusch, H.W., Ultrastructure of aberrant serotonin-immunoreactive fibers in the caudate putamen complex of the aged rat. Synapse 8 (1991), 162–168.
67. van Rooden, S.M., Colas, F., Martinez-Martin, P., Visser, M., Verbaan, D., Marinus, J., Chaudhuri, R.K., Kok, J.N., van Hilten, J.J., Clinical subtypes of Parkinson's disease. Mov. Disord. 26 (2011), 51–58.
68. West, M.J., Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 22 (1999), 51–61.
69. Zhou, F.C., Sharon Bledsoe, J.M., Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain. Brain Res. 556 (1991), 108–116.